Stocks
ABIOMED (ABMD) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | LTM ? | CAGR 5 years ? | |||||
| R&D/CAPEX, % | 228.3% | 456.9% | 623.6% | ||||||
| Changes by years, y/y, % | +4pp | -228pp | +28.3% | ||||||
ABIOMED. R&D/CAPEX, %
ABIOMED. R&D/CAPEX, changes, pp
ABIOMED (ABMD) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2022Q3 | 2022Q4 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| R&D/CAPEX, % | 630.9% | 294.0% | 596.7% | 750.4% | 623.6% | |||
| Changes by years, y/y, % | +203pp | -123pp | +172pp | +71pp | +182pp | |||
| Changes by quarters, q/q, % | -631pp | +303pp | +154pp | |||||
